Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
7.33
-0.08 (-1.08%)
At close: Aug 1, 2025, 4:00 PM
7.47
+0.14 (1.91%)
After-hours: Aug 1, 2025, 6:16 PM EDT
Intra-Cellular Therapies Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$19.94
Upside
+172.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $25 | Buy | Initiates | $25 | +241.06% | Jul 1, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +186.49% | Jun 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +186.49% | May 28, 2025 |
| Needham | Needham | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +227.42% | May 20, 2025 |
| Needham | Needham | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +227.42% | Apr 8, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $11 → $20 | Strong Buy | Reiterates | $11 → $20 | +172.85% | Mar 19, 2025 |
| Needham | Needham | Strong Buy Maintains $25 → $24 | Strong Buy | Maintains | $25 → $24 | +227.42% | Mar 19, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +186.49% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +70.53% | Mar 19, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $12 → $20 | Buy | Maintains | $12 → $20 | +172.85% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7.5 → $13 | Strong Buy | Maintains | $7.5 → $13 | +70.53% | Mar 10, 2025 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $9 → $29 | Buy → Strong Buy | Upgrades | $9 → $29 | +295.63% | Mar 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +186.49% | Mar 10, 2025 |
| Needham | Needham | Strong Buy Maintains $8 → $25 | Strong Buy | Maintains | $8 → $25 | +241.06% | Mar 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +186.49% | Mar 7, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +186.49% | Feb 24, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.